B、C基因型乙型肝炎病毒X蛋白对MDR1基因的反式激活能力不同
发布时间:2017-12-30 21:07
本文关键词:B、C基因型乙型肝炎病毒X蛋白对MDR1基因的反式激活能力不同 出处:《福建医科大学》2008年硕士论文 论文类型:学位论文
更多相关文章: 乙型肝炎病毒 基因型 反式激活 多药耐药基因
【摘要】: 目的:研究B、C基因型乙型肝炎病毒(HBV)X蛋白对多药耐药基因1(Multidrug resisitance gene 1,MDR1)反式激活能力的差别。 方法: PCR扩增B、C基因型HBV X基因并克隆于pcDNA3.1/HisC载体(重组载体分别为pcDNA3.1/HisC-XB及pcDNA3.1/HisC-XC)。以FuGENE6将重组表达载体转染HepG2细胞,采用融合表达的X-press多肽表位抗体,通过western blot检测目的蛋白在不同时间段的表达。PCR扩增MDR1基因启动子并克隆于萤火虫荧光素酶报告载体pGL3-Basi(c重组载体为pGL-MDR)。pGL-MDR分别与pcDNA3.1/HisC-XB或pcDNA3.1/HisC-XC共转染HepG2细胞,转染后48小时裂解细胞并检测胞内萤火虫荧光素酶活性,实验数据以SPSS 11.5软件分析。 结果: 1、成功克隆X蛋白表达载体及MDR1报告载体。Western blot显示pcDNA3.1/HisC-XB或pcDNA3.1/HisC-XC在HepG2细胞中均能表达HBV X蛋白,以转染后48小时为最高;2、当pGL-MDR报告质粒与X基因重组载体或空载体质量比在1:2~1:4范围内,萤火虫荧光素酶在各转染细胞内的活性依次为pcDNA3.1/HisC-XB+pGL-MDR组pcDNA3.1/HisC-XC+pGL-MDR组pcDNA3.1/HisC+pGL-MDR组(对照组),且存在剂量-效应关系。 结论: B、C基因型HBV X蛋白对多药耐药基因均有反式激活能力,且B基因型强于C基因型。
[Abstract]:Objective: to study the multidrug resisitance gene 1 (MDR) gene of hepatitis B virus (HBV) resisitance gene X protein (HBVX). MDR1) the difference in transactivation ability. Methods: B was amplified by PCR. C genotype HBV X gene was cloned into pcDNA3.1/HisC vector (. The recombinant vectors were pcDNA3.1/HisC-XB and pcDNA3.1 / HisC-XCn.Recombinant expression vectors were transfected into HepG2 cells by FuGENE6. The fusion expressed X-press peptide epitope antibody was used. The promoter of MDR1 gene was amplified by western blot and cloned into the luciferase report vector pGL3-Basi. C Recombinant vector pGL-MDR).pGL-MDR was cotransfected with pcDNA3.1/HisC-XB or pcDNA3.1/HisC-XC into HepG2 cells respectively. 48 hours after transfection, the cells were lysed and the luciferase activity of firefly was detected. The experimental data were analyzed by SPSS 11.5 software. Results: 1. Successful cloning of X protein expression Vector and MDR1 report Vector. Blot showed that both pcDNA3.1/HisC-XB and pcDNA3.1/HisC-XC could express HBV X protein in HepG2 cells. The highest rate was 48 hours after transfection. 2, when the mass ratio of pGL-MDR report plasmid to X gene recombinant vector or empty vector is in the range of 1: 2 and 1: 4. The luciferase activity of firefly in the transfected cells was in turn pcDNA3.1/HisC-XB pGL-MDR group pcDNA3.1/HisC-XC. PGL-MDR group pcDNA3.1/HisC pGL-MDR group (. Control group). And there is a dose-effect relationship. Conclusion: HBV X protein of genotype B C has transactivation ability to multidrug resistance genes, and genotype B is stronger than genotype C.
【学位授予单位】:福建医科大学
【学位级别】:硕士
【学位授予年份】:2008
【分类号】:R373
【参考文献】
相关期刊论文 前3条
1 林旭,徐晓,黄清玲,郑大利,林建银;B、C基因型乙型肝炎病毒X蛋白结构对反式激活能力影响[J];中华微生物学和免疫学杂志;2004年07期
2 ;Biological impacts of "hot-spot" mutations of hepatitis B virus X proteins are genotype B and C differentiated[J];World Journal of Gastroenterology;2005年30期
3 Myron J Tong;Lawrence M Blatt;Jia-Horng Kao;Jason Tzuying Cheng;William G Corey;;Precore/basal core promoter mutants and hepatitis B viral DNA levels as predictors for liver deaths and hepatocellular carcinoma[J];World Journal of Gastroenterology;2006年41期
,本文编号:1356504
本文链接:https://www.wllwen.com/yixuelunwen/shiyanyixue/1356504.html
最近更新
教材专著